O
CLVS
OrbiMed’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,913,234
| Closed | -$28.5M | – | 133 |
|
|
2019
Q2 | $28.5M | Sell |
1,913,234
-919,066
| -32% | -$13.7M | 0.44% | 54 |
|
|
2019
Q1 | $70.3M | Buy |
2,832,300
+80,100
| +3% | +$1.99M | 1.09% | 29 |
|
|
2018
Q4 | $49.4M | Buy |
2,752,200
+517,630
| +23% | +$9.3M | 0.91% | 37 |
|
|
2018
Q3 | $65.6M | Sell |
2,234,570
-96,300
| -4% | -$2.83M | 0.79% | 39 |
|
|
2018
Q2 | $106M | Hold |
2,330,870
| – | – | 1.26% | 26 |
|
|
2018
Q1 | $123M | Buy |
2,330,870
+359,200
| +18% | +$19M | 1.53% | 19 |
|
|
2017
Q4 | $134M | Sell |
1,971,670
-417,000
| -17% | -$28.4M | 1.7% | 18 |
|
|
2017
Q3 | $197M | Buy |
2,388,670
+284,300
| +14% | +$23.4M | 1.88% | 15 |
|
|
2017
Q2 | $197M | Buy |
+2,104,370
| New | +$197M | 2.07% | 16 |
|
|
2016
Q2 | – | Sell |
-660,900
| Closed | -$12.7M | – | 142 |
|
|
2016
Q1 | $12.7M | Sell |
660,900
-68,700
| -9% | -$1.32M | 0.13% | 79 |
|
|
2015
Q4 | $25.5M | Sell |
729,600
-376,300
| -34% | -$13.2M | 0.23% | 68 |
|
|
2015
Q3 | $102M | Buy |
1,105,900
+100,700
| +10% | +$9.26M | 1.03% | 35 |
|
|
2015
Q2 | $88.3M | Buy |
1,005,200
+4,800
| +0.5% | +$422K | 0.74% | 40 |
|
|
2015
Q1 | $74.3M | Buy |
1,000,400
+286,300
| +40% | +$21.3M | 0.63% | 44 |
|
|
2014
Q4 | $40M | Buy |
+714,100
| New | +$40M | 0.38% | 54 |
|